NCT03185468View on ClinicalTrials.gov

Intervention of Bladder Cancer by CAR-T

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Bladder CancerUrothelial Carcinoma Bladder
Interventions
GENETIC

4SCAR-PSMA

PSMA-specific 4th Generation CART

GENETIC

4SCAR-FRa

FRa-specific 4th Generation CART

Trial Locations (2)

518000

RECRUITING

Shenzhen Geno-immune Medical Institute, Shenzhen

Unknown

RECRUITING

Shenzhen Second People Hospital, Shenzhen

All Listed Sponsors
lead

Shenzhen Geno-Immune Medical Institute

OTHER

NCT03185468 - Intervention of Bladder Cancer by CAR-T | Biotech Hunter | Biotech Hunter